Johnson & Johnson (JNJ) Share-based Compensation (2009 - 2026)

Johnson & Johnson (JNJ) has 18 years of Share-based Compensation data on file, last reported at $300.0 million in Q1 2026.

• Quarterly Share-based Compensation rose 4.17% year-over-year to $300.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 billion (up 17.56% YoY) and the FY2025 annual result came in at $1.4 billion, up 15.14% from the prior year.
• Share-based Compensation slipped to $300.0 million in Q1 2026 per JNJ's latest filing, from $309.0 million in the prior quarter.
• The five-year high for Share-based Compensation was $410.0 million in Q2 2025, with the low at $178.0 million in Q4 2023.
• Average Share-based Compensation over 5 years is $299.2 million, with a median of $300.0 million recorded in 2026.
• Year-over-year, Share-based Compensation retreated 18.35% in 2023 and soared 33.71% in 2024.
• Johnson & Johnson's Share-based Compensation stood at $278.0 million in 2022, then tumbled by 35.97% to $178.0 million in 2023, then jumped by 33.71% to $238.0 million in 2024, then advanced by 29.83% to $309.0 million in 2025, then fell by 2.91% to $300.0 million in 2026.
• Business Quant data shows JNJ's Share-based Compensation at $300.0 million in Q1 2026, $309.0 million in Q4 2025, and $347.0 million in Q3 2025.